We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Product News   Aug 14, 2017

 
BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Credit: BellBrook Labs

 
 
FURTHER INFORMATION
 
 
 

Related Product News

LGC Announces New, Integrated, Global Portfolio Brand, Biosearch Technologies

Product News

Representing genomic tools for mission critical customer applications.

READ MORE

OGT further expands global direct sales and support into Asia-Pacific region

Product News

Following successful European rollout, more customers to benefit from enhanced local sales and support services.

READ MORE

Arbor Biosciences Launches Cell-Free Linear DNA Expression System

Product News

New E. coli-based Cell-Free Expression System will accelerate synthetic biology research and protein discovery through expression from PCR products and gene fragments.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE